Font: Financial Modeling Prep • Feb 23, 2026
Freshpet Inc. (NASDAQ: FRPT) reported fourth-quarter results that exceeded earnings expectations but narrowly missed revenue forecasts, sending shares up more than 4% intra-day Monday.
The pet food company posted adjusted earnings per share of $0.64, outperforming the consensus estimate of $0.41 by $0.23.
Revenue totaled $285.2 million, slightly below the $285.7 million estimate but representing an 8.6% increase from $262.7 million in the prior-year period. Growth was driven by a 9.7% increase in volume, partially offset by an unfavorable price/mix impact of 1.1%.
For fiscal 2026, Freshpet projected net sales growth of 7% to 10%, equating to revenue between $1.179 billion and $1.212 billion. The midpoint of $1.196 billion reflects approximately 8.5% growth. The company expects adjusted EBITDA in the range of $205 million to $215 million, with a midpoint of $210 million compared to $195.7 million in 2025.
For full-year 2025, net sales rose 13% to $1.102 billion. Adjusted EBITDA increased to $195.7 million from $161.8 million the previous year. The company generated positive free cash flow of $12.4 million, compared with negative $32.8 million in 2024.
|
SOXS§>
Direxion Daily Semiconductor Bear 3X Shares
|
$1.66
-4.60%
|
|
BHAT§>
Fujian Blue Hat Interactive Entertainment Technology Ltd.
|
$0.07
6.84%
|
|
EZRA§>
Reliance Global Group Inc.
|
$0.29
11.37%
|
|
BRTX§>
BioRestorative Therapies, Inc.
|
$0.27
37.01%
|
|
NVDA§>
NVIDIA Corporation
|
$192.85
0.68%
|
|
ZSL§>
ProShares UltraShort Silver
|
$1.88
3.87%
|
|
TLIH§>
Ten-League International Holdings Limited Ordinary Shares
|
$0.44
37.74%
|
|
TZA§>
Direxion Daily Small Cap Bear 3X Shares
|
$6.09
-3.33%
|
|
INTC§>
Intel Corporation
|
$46.12
5.71%
|
|
EDSA§>
Edesa Biotech, Inc.
|
$1.51
67.96%
|